Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy

Laboratory Investigation

Volumn 91, Issue 1, 2011, Pages 63-84

  Park, Sang Won ^a   Chen, Sean W ^a   Kim, Mihwa ^a   Brown, Kevin M ^a   Kolls, Jay K ^b   D'Agati, Vivette D ^a   Lee, H Thomas ^a  

^a Columbia University ^*  (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute kidney injury; apoptosis; inflammation; multi organ dysfunction; necrosis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL VACUOLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOMODULATION; INFLAMMATION; INTESTINE INJURY; KIDNEY ISCHEMIA; LIVER DYSFUNCTION; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; MOUSE; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OUTCOME ASSESSMENT; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROTEIN DETERMINATION; REPERFUSION; UPREGULATION;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CAPILLARY PERMEABILITY; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-6; INTESTINE, SMALL; KIDNEY; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRECTOMY; RECEPTORS, INTERLEUKIN-17; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650787485     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.151     Document Type: Article

References (46)

1. Jones DR, Lee HT. Perioperative renal protection. Best Pract Res Clin Anaesthesiol 2008;22:193-208.
2. Bove T, Calabro MG, Landoni G, et al. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 2004;18:442-445.
3. Elapavaluru S, Kellum JA. Why do patients die of acute kidney injury? Acta Clin Belg Suppl 2007;2:326-331.
4. Paladino JD, Hotchkiss JR, Rabb H. Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease? Microvasc Res 2009;77:8-12.
5. Grigoryev DN, Liu M, Hassoun HT, et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008;19:547-558.
6. Faubel S. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis 2008;15:284-296.
7. Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005;9: R700-R709.
8. Burne-Taney MJ, Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens 2003; 12:85-90.
9. Rabb H. Immune modulation of acute kidney injury. J Am Soc Nephrol 2006;17:604-606.
10. Donnahoo KK, Meldrum DR, Shenkar R, et al. Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 2000;163:1328-1332.
11. Donnahoo KK, Meng X, Ayala A, et al. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999;277:R922-R929.
12. Kielar ML, John R, Bennett M, et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005;16:3315-3325.
13. Liu KD, Altmann C, Smits G, et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care 2009;13:R104.
14. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006;126:1121-1133.
15. Lee HT, Gallos G, Nasr SH, et al. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2004;15:102-111.
16. Park SW, Chen SW, Kim M, et al. Human heat shock protein 27 overexpressing mice are protected against acute kidney injury after hepatic ischemia and reperfusion. Am J Physiol Renal Physiol 2009;297:F885-F894.
17. Lee HT, Park SW, Kim M, et al. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest 2009;89:196-208.
18. Park SW, Chen SW, Kim M, et al. Human activated protein C attenuates both hepatic and renal injury caused by hepatic ischemia and reperfusion injury in mice. Kidney Int 2009;76:739-750.
19. SLOT C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965;17:381-387.
20. Hart ML, Henn M, Kohler D, et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 2008;22:2784-2797.
21. Chen SW, Park SW, Kim M, et al. Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. Transplantation 2009;87:1478-1487.
22. Park SW, Kim M, Chen SWC, et al. Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock 2009;33:31-42.
23. Herrmann M, Lorenz HM, Voll R, et al. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 1994;22:5506-5507.
24. Faubel S. Acute kidney injury and multiple organ dysfunction sindrome. Minerva Urol Nefrol 2009;61:171-188.
25. Hassoun H, Grigoryev DN, Lie M, et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol 2007;293:F30-F40.
26. Knaus WA, Draper EA, Wagner DP, et al. Prognosis in acute organ-system failure. Ann Surg 1985;202:685-693.
27. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000;28:2193-2200.
28. Golab F, Kadkhodaee M, Zahmatkesh M, et al. Ischemic and non-ischemic acute kidney injury cause hepatic damage. Kidney Int 2009;75:783-792.
29. Fadillioglu E, Kurcer Z, Parlakpinar H, et al. Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res 2008;31:705-712.
30. Wang BY, Li QX, Li J, et al. Hepatotoxicity and gene expression down-regulation of CYP isozymes caused by renal ischemia/reperfusion in the rat. Exp Toxicol Pathol 2009;61:169-176.
31. Serteser M, Koken T, Kahraman A, et al. Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/ reperfusion injury in mice. J Surg Res 2002;107:234-240.
32. Yang S, Koo DJ, Chaudry IH, et al. The important role of the gut in initiating the hyperdynamic response during early sepsis. J Surg Res 2000;89:31-37.
33. Pabst R. The anatomical basis for the immune function of the gut. Anat Embryol Berl 1987;176:135-144.
34. Shealy DJ, Visvanathan S. Anti-TNF antibodies: lessons from the past, roadmap for the future. Handb Exp Pharmacol 2008;181:101-129.
35. Kramer JM, Hanel W, Shen F, et al. Cutting edge: identification of a pre-ligand assembly domain PLAD; and ligand binding site in the IL-17 receptor. J Immunol 2007;179:6379-6383.
36. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002;17:375-387.
37. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
38. Atarashi K, Nishimura J, Shima T, et al. ATP drives lamina propria TH;17 cell differentiation. Nature 2008;455:808-812.
39. Takahashi N, Vanlaere I, de RR, et al. IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med 2008;205:1755-1761.
40. Gaffen SL, Kramer JM, Yu JJ, et al. The IL-17 cytokine family. Vitam Horm 2006;74:255-282.
41. Andoh A, Hata K, Araki Y, et al. Interleukin IL;-4 and IL-17 synergistically stimulate IL-6 secretion in human colonic myofibroblasts. Int J Mol Med 2002;10:631-634.
42. Shimada M, Andoh A, Hata K, et al. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol 2002;168:861-868.
43. Hata K, Andoh A, Shimada M, et al. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2002;282: G1035-G1044.
44. Wang W, Smail N, Wang P, et al. Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. J Surg Res 1998;79:39-46.
45. Ding C, Cicuttini F, Li J, et al. Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opin Investig Drugs 2009;18:1457-1466.
46. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110:835-842.